Core Laboratories (CLB) Cost of Revenue (2022 - 2026)
Core Laboratories filings provide 5 years of Cost of Revenue readings, the most recent being $26.0 million for Q1 2026.
- On a quarterly basis, Cost of Revenue fell 2.0% to $26.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $346.6 million, a 70.53% increase, with the full-year FY2025 number at $302.2 million, up 1.64% from a year prior.
- Cost of Revenue hit $26.0 million in Q1 2026 for Core Laboratories, down from $216.1 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $216.1 million in Q4 2025 to a low of -$85.3 million in Q4 2022.
- Median Cost of Revenue over the past 5 years was $30.1 million (2022), compared with a mean of $42.1 million.
- The widest YoY moves for Cost of Revenue: up 195.44% in 2025, down 13.78% in 2025.
- Core Laboratories' Cost of Revenue stood at -$85.3 million in 2022, then surged by 135.66% to $30.4 million in 2023, then skyrocketed by 140.47% to $73.1 million in 2024, then skyrocketed by 195.44% to $216.1 million in 2025, then plummeted by 87.99% to $26.0 million in 2026.
- The last three reported values for Cost of Revenue were $26.0 million (Q1 2026), $216.1 million (Q4 2025), and $74.9 million (Q3 2025) per Business Quant data.